Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Becton Dickinson's (NYSE:BDX) Quiet Reset Is Gathering Pace, Could Its Portfolio Transformation Unlock Growth?

Dickinson (NYSE:BDX). The transaction that defined BD's last two years is complete. The company spun off its Biosciences and Diagnostic Solutions businesses and merged them with a WatersSubsidiaryin a tax-efficientReverse Morris Trustvalued at roughly $17.5 billion when announced. BD shareholders of record on 5 …

Nitish Kishor | 03 August 2026

Microsoft's Xbox Chief Aims to Surpass Rivals on Margin by 2030

Xbox aims to raise its profitMarginto outpace rivals by 2030, targeting a clear margin premium. This premium underpins a more resilientEarningsprofile and supports long‑termShareholdervalue.Key HighlightsXbox chief sets a margin‑focused target aimed at outpacing rivals by 2030.The strategy emphasizes subscription growth, cloud integration, and cost‑efficient …

Vinay Lochav | 03 August 2026

Abbott (NYSE:ABT) Raises Its 2026 Profit Outlook, Is the Market Still Underestimating This Healthcare Giant?

Abbott (NYSE:ABT) reported second-quarter 2026 sales of $12.593 billion on 16 July, up 13.0% as reported and 4.8% on an organic basis, with adjusted diluted earnings of $1.31 per share against a consensus of $1.28.Revenuealso came in ahead of the roughly $12.50 billion analysts …

Nitish Kishor | 03 August 2026

AbbVie (NYSE:ABBV): Skyrizi and Rinvoq Are Booming. So Why Did AbbVie Shares Fall 2.5%?

AbbVie (NYSE:ABBV) reported second-quarter results before the open at last closing and did nearly everything asked of it. Net revenue rose 10.2% on a reported basis to $16.990 billion, ahead of the roughly $16.77 billion analysts had modeled. Skyrizi and Rinvoq, the pair engineered …

Nitish Kishor | 03 August 2026

Agilent (NYSE:A) Jumped 17% on One Earnings Print, Can the Laboratory-Spending Cycle Carry the Re-Rating Further?

Technologies (NYSE:A). For most of fiscal 2024 and 2025, owning analytical-instrument makers was an exercise in waiting out a hangover. Laboratory customers who had over-ordered during thePandemicsimply stopped buying. Revenue fell 4.7% in fiscal 2024 to $6.51 billion after a flat fiscal 2023, then …

Nitish Kishor | 03 August 2026

Align Technology (NASDAQ:ALGN) Falls After a Record Quarter, Is the Clear-Aligner Boom Entering a New Phase?

Technology (Nasdaq:ALGN). Second-quarter revenue of $1,056.2 million, reported on 29 July, was the highest in the company's history, up 4.3% year over year. Clear Aligner shipments of 691,785 cases were also a record, up 7.4%. Non-GAAPEarningsof $2.64 a share beat the $2.60 consensus tracked …

Nitish Kishor | 03 August 2026

Palantir (NYSE: PLTR) Q2 2026 Earnings Preview: What to Watch Ahead of Today's Report

Palantir (NYSE: PLTR) is scheduled to report Q2 2026 results today, Monday, August 3, 2026, after the U.S. market close, with a webcast set for 5:00 PM ET, giving investors their next look at whether the company's rapid growth and expanding profitability have continued …

Nitish Kishor | 03 August 2026

Meta Faces Investor Backlash Over Unclear AI Spending Strategies

Meta has come under fire from technology investors who are demanding clearer explanations regarding itsArtificial Intelligence (AI)expenditure. Investors have expressed their concerns that theSocial Mediagiant lacks a definitive strategy in an increasingly competitive AI arena. As companies such as Microsoft are viewed as more …

Vinay Lochav | 03 August 2026

Meta (NASDAQ: META) Q2 EPS Falls 14% to $6.18, Free Cash Flow Plunges 91%

Meta reported a mixed earnings picture that sent theNasdaq‑100 and global ad‑tech stocks lower on the day. Revenue surged 27.96% YoY to $60.80 billion, withAdvertisingalone delivering $59.36 billion, a 27% increase that kept the company’sTop Linestrong despite a sharp earnings miss. Daily active users …

Vinay Lochav | 03 August 2026

SCYNEXIS (NASDAQ:SCYX) Leaps 29.8%: Are Investors Finally Waking Up to Its Rare-Disease Pipeline?

SCYNEXIS (Nasdaq:SCYX) closed on Friday 31 July 2026 up 29.76% at $4.84 on the TradingView screener, on roughly 3.18 million shares. A second data provider records the close at $4.81 and the gain at 28.95%; the difference is a feed variance rather than a …

Nitish Kishor | 03 August 2026
Support

Hi! How can we help you today?

Loading…